DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Ferolla P. et al.
Shortened interval of long-acting octreotide administration is effective in patients with well-differenziated neuroendocrine carcinomas in progression on standard doses.

J Endocrinol Invest 2012;
35: 326-331

Download Bibliographical Data

Search in: